Healthcare, Pharmaceuticals & Biotech
The healthcare market is continuously evolving. This is mainly due to an ageing population, efficiency improvements, disease management, emerging regions, new diagnostics and therapies. The most important growth areas are within Biotech, Software and Service Provision.
Over 10,000 transactions are closed annually in this area. 60% in the US, and 25% in Europe.
Pharmaceuticals and Biotech represent over 40% of the deals, with service and product suppliers coming in second and third consecutively.
Almost 70% of the deals are smaller than $100m.